Sun, Oct 26, 2014, 3:45 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Pluristem Therapeutics, Inc. Message Board

  • gswkool gswkool Mar 3, 2013 2:54 PM Flag

    nice pipeline and two orphan drug designations

    Review their pipeline and addressable market sizes $$ on their website. They have two orphan drug designations. I think what it must come down to is that in general there are a lot of doubters out there when it comes to stem cells. I can't see any other reason for the cheap share price. You are either open to the possibility or not. Personally, I believe in the potential of stem cells and have placed my bets on PSTI and ACTC as part of a diversified biotech portfolio. Big pharma has a lot of cash to play with and drugs coming off patent to replace. With any success in this space, the deals will really begin to flow with stock prices to follow....other biotechs I'm holding are LXRX, SGMO, VICL, PSDV, FOLD, GERN, CCXI, PRAN, ALNY, NVAX, SNMX, NVIV, & BLRX ......Good luck to all

    SortNewest  |  Oldest  |  Most Replied Expand all replies
2.95+0.01(+0.34%)Oct 24 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
NYSEFri, Oct 24, 2014 4:04 PM EDT